PMID: 42545321

[Safety Management of Incretin-Based Obesity Therapy: Expert Consensus on the Use of Semaglutide and Tirzepatide].

Troshina E A, Antsiferov M B, Ametov A S, Bakulin I G, Galstyan G R, Markova T N, Romantsova T I, Mazurina N V, Koteshkova O M

Problemy endokrinologii · 2026

Vol. 72, Issue 3, pp. 36-43

This entry links to third-party literature. For research use only.